Plex Research is partnering with Ginkgo Bioworks to use AI to deepen understanding of the mechanisms of action of existing ...

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

The company aims to build an AI-powered discovery platform for defense attorneys, backed by venture capital firm UpWest, ...

New center will use cutting-edge AI to accelerate the creation of life-saving medicines AI Small Molecule Drug Discovery ...

APL and Microsoft are partnering to advance robotics and materials discovery by leveraging artificial intelligence (AI).

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

Christopher Bishop has been at the forefront of Microsoft’s artificial intelligence applications for some time since he runs the company’s AI for Science research unit, which applies the powerful ...

Artificial intelligence (AI) is making significant strides in various fields, with drug discovery being one of the most impactful areas. The process of developing new drugs has traditionally been a ...

Artificial intelligence (AI) is changing the world. Corporations are racing to establish themselves as leaders in the field, ...

With basic attorney training and achievable deployment, AI will reduce the risk of malpractice in 2025, not expand it.

Learn about and respond to a U.S. Navy request for information, which could result in request for prototype proposal.

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.